In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 6, 1996, Pages 1508-1513

  Ford, Charles W ^a   Hamel, Judith C ^a   Wilson, Debbie M ^a   Moerman, Judy K ^a   Stapert, Douglas ^a   Yancey Jr , Robert J ^a   Hutchinson, Douglas K ^a   Barbachyn, Michael R ^a   Brickner, Steven J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFACLOR; CLINDAMYCIN; EPEREZOLID; GENTAMICIN; LINEZOLID; METICILLIN; OXAZOLIDINE DERIVATIVE; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; ENTEROCOCCUS FAECALIS; NONHUMAN; PRIORITY JOURNAL; SEPTICEMIA; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0029940428     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.6.1508     Document Type: Article

References (19)

1. Barry, A. L. 1988. In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents. Antimicrob. Agents Chemother. 32:150-152
2. Brickner, S. J., P. R. Manninen, D. A. Ulanowicz, K. D. Lovasz, and D. C. Rohrer. 1993. Multicyclic fused-ring oxazolidinone antibacterial agents, abstr. 89. In Abstracts of Papers of the 206th National Meeting of the American Chemical Society American Chemical Society, Washington, D.C
3. Brook, I., and E. H. Frazier. 1990. Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses. Arch. Surg. 125:1445-1451.
4. Brumfitt, W., and J. M. Hamilton-Miller. 1988. In vitro microbiological activities of DuP 105 and DuP 721, novel synthetic oxazolidinones. J Antimicrob Chemother 21:711-720.
5. Daly, J. S., G. M. Eliopoulos, E. Reiszner, and R. C. Moellering, Jr. 1988. Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds. J. Antimicrob Chemother. 21:721-730.
6. Daly, J. S., G. M. Eliopoulos, S. Willey, and R. C. Moellering, Jr. 1988. Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound. Antimicrob. Agents Chemother 32:1341-1346.
7. Dudley, M. 1995. Bacterial resistance mechanisms to β-lactam antibiotics, assessment of management strategies. Pharmacotherapy 15(Suppl.):9-14.
8. Eustice, D. C., P. A. Feldman, and A. M. Slee. 1988. The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis. Biochem. Biophys. Res. Commun. 150:965-971.
9. Eustice, D. C., P. A. Feldman, I. Zajac, and A. M. Slee. 1988. Mechanism of action of DuP 721 inhibition of an early event in protein synthesis. Antimicrob. Agents Chemother 32:1218-1222.
10. Ford, C. W., J. C. Hamel, D. Stapert, and R. J. Yancey, Jr. 1988. Establishment of an experimental model of a Staphylococcus aureus abscess in mice by the use of dextran and gelatin microcarriers. J. Med Microbiol. 28:259-268
11. Koike, S., H. Miura, R. Nakamura, K. Chiba, and J. B. Moe. 1995. Drug safety studies with a novel oxazolidinone, U-100766, abstr. F224, p. 152. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C
12. Martin, I. J., and P. T. Daley-Yates. 1995. The metabolism and kinetics of a novel oxazolidinone, U-100592, abstr. F222, p. 151. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. National Committee for Clinical Laboratory Standards. 1993. Approved standard Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. National Committee for Clinical Laboratory Standards. 1993. Approved standard. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 3rd ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. Neu, H. C., A. Novelli, G. Saba, and N. X. Chin. 1988. In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105. Antimicrob. Agents Chemother 32:580-583.
16. Slee, A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, M. J. Zawada, P. T. Bartholomew, W. A. Gregory, and M. Forbes. 1987. Oxazolidinones, a new class of synthetic antibacterials: in vitro and in vivo activities of DuP 105 and DuP 721, abstr. 244, p. 139. In Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
17. Slee, A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, M. J. Zawada, P. T. Bartholomew, W. A. Gregory, and M. Forbes. 1987. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721. Antimicrob Agents Chemother. 31:1791-1797
18. Zajac, I., G. N. Lam, H. E. Hoffman, and A. M. Slee. 1987. Pharmacokinetics of DuP 721, a new synthetic oxazolidinone antibacterial, abstr. 247, p. 140. In Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C
19. Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1995. In vitro antibacterial activity of U-100592 and U-100766, novel oxazolidinone antibiotics, abstr. F216, p. 150. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D C.